SecBot SecBot
PRESS-RELEASE ·Filed Nov 2, 2026

OSUR

OraSure Technologies, Inc.
NEUTRAL
Impact 2/10
Horizonmonths Processed14d 21h ago WireGlobeNewswire
Press release · Contract
Actionable Insight • Neutral

This is a non-material partnership announcement with no disclosed financial terms. Monitor for future updates on specific contracts or revenue contributions from sickle cell disease diagnostics.

DirectionNeutral
Confidencehigh
Horizonmonths

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$3.46
T+0 close · Nov 2, 2026 · via day close
Latest settled
+2.17%
T+5 · $3.53 · next T+20 in 14d
Vs SPY
+2.09%
α at T+5
Latest observation
+4.91%
T+9 · FF3 residual α
  1. T+0 · Nov 2 $3.46entry
  2. T+1 · 14d ago +2.17%α +1.87% · $3.53
  3. T+5 · 8d ago +2.17%α +2.09% · $3.53
  4. T+10 · todayOpen
  5. T+20 · in 14d Pending
  6. T+60 · in 2mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

OraSure Technologies announced its membership in the World Coalition on Sickle Cell Disease, a public-private partnership focused on improving global sickle cell disease care. The company will contribute diagnostics expertise, particularly in decentralized and point-of-care testing, to support early diagnosis and linkage to care. No financial terms or material revenue impact were disclosed.

Key Facts

  • OraSure joined the World Coalition on Sickle Cell Disease, an international public-private partnership.
  • The coalition includes patient advocacy groups, governments, healthcare providers, researchers, and private sector entities.
  • OraSure will provide a diagnostics manufacturer perspective, focusing on decentralized and point-of-care testing.
  • No financial terms, contract value, or revenue guidance were disclosed in the announcement.

Financial Impact

No financial terms disclosed; the announcement is a non-binding membership with no stated revenue or cost impact.

Risk Factors

  • No financial details provided; the partnership may not lead to material revenue.
  • The announcement lacks specific milestones or timelines for commercialization.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
0% bullish (6 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3392914

Track record

20 reports on OSUR

Performance horizon

6 of 6 bullish or bearish reports moved the stock their way by T+1. Best: +39.73% at T+60 after the Mar 13, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 2/10 Entry $3.62 to $3.62 Now $3.60 −0.55% · 0.00% +0.36% vs SPY
  2. Nov 9, 20267d ago Press Release Neutral 4/10 Entry $3.33 to $3.56 Now $3.60 +8.11% ▲ +6.91% +5.59% vs SPY
  3. Nov 9, 20267d ago SC 13G/A Neutral 3/10 Entry $3.53 to $3.33 Now $3.60 +1.98% ▼ −5.67% −5.30% vs SPY
  4. Nov 2, 202614d ago Press Release Neutral 2/10 Viewing Entry $3.46 to $3.53 Now $3.60 +4.20% ▲ +2.17% +1.87% vs SPY
  5. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $3.94 to $3.46 Now $3.60 −8.63% ▼ −12.31% −11.83% vs SPY
  6. Sep 17, 20268w ago SC 13D Bullish 6/10 Entry $3.56 to $3.69 Now $3.60 +1.12% ▲ +3.65% +2.10% vs SPY
  7. Jul 23, 202616w ago Court Ruling Neutral 3/10 Entry $3.97 to $3.96 Now $3.60 −9.32% ▼ −0.25% −0.27% vs SPY
  8. Jun 12, 202622w ago Institutional Cluster Mixed 4/10 Entry $4.18 to $4.17 Now $3.60 −13.88% ▼ −0.24% −2.00% vs SPY
  9. Jun 3, 202623w ago 8-K Neutral 3/10 Entry $4.17 to $4.04 Now $3.60 −13.67% ▼ −3.12% −0.52% vs SPY
  10. May 6, 202627w ago 8-K Bearish 6/10 Entry $3.13 to $3.06 Now $3.60 −15.02% ▲ +2.24% +3.07% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026